Clinical trial · Observational
Shared Decision Making in Low Risk Prostate Cancer
Shared Decision Making: A Study Assessing the Benefit of a Web Based Aid Presenting Treatment Options for Patients With Low Risk Prostate Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Due to unforeseen changes in study personnel, the study was not initiated.
Summary
Brief summary (as posted)
This study will evaluate the usefulness of an informational website designed to educate patients with prostate cancer about their options for treatment. The investigators hope that this website will assist patients with making informed decisions about their care and improving their satisfaction with the treatments they choose.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Low risk prostate cancer
- interventionNames
- Other: Survey
Primary outcomes (1)
- measure
- Patient knowledge regarding the available treatment options for low-risk prostate cancer and their potential side effects.
- timeFrame
- 2 years
- description
- Investigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
Secondary outcomes (4)
- measure
- Decisional conflict and informed decision making experienced by patients.
- timeFrame
- 2 years
- description
- Investigators will assess the impact of an informational website developed specifically to assist low-risk prostate cancer patients with knowledge of their disease and treatment options. This will be measured by patient responses to questionnaires compiled from validated sources.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed prostate adenocarcinoma * Internet access * Able to read and understand English Exclusion Criteria: * Evidence of nodal metastases * Evidence of distant metastases * Prior surgery, chemotherapy, pelvic radiation or prostate brachytherapy for prostate cancer
References
Publications (0)
Data not yet available